Proposed PFAS Rule Would Cost Companies Estimated $1B; Lacks Limits and Cleanup Requirement

A proposed Environmental Protection Agency rule calls for companies to disclose PFAS manufactured or imported since 2011. The chemical industry is upset because such compliance would cost an estimated $1 billion, while environmental health advocates worry because the rule wouldn’t ban the chemicals outright.

CDC to Reduce Funding for States’ Child Vaccination Programs

Citing the recent debt ceiling deal, the CDC is trimming its funding to child vaccination programs that focus on communities vulnerable to disease outbreaks. The cuts come despite data showing the percentage of children getting vaccinated has dropped in recent years.

As Low-Nicotine Cigarettes Hit the Market, Anti-Smoking Groups Press for Wider Standard

The first FDA-authorized cigarettes with 95% less nicotine than traditional smokes will go on sale in California, Florida, and Texas starting in early July. Anti-smoking groups oppose greenlighting just one plant biotech’s products and instead urge federal regulators to set a low-nicotine standard for the entire industry.

New Charleston Museum Nods to Historical Roots of US Health Disparities

The $120 million International African American Museum that opened this week in Charleston, South Carolina, allows visitors to step back in history at Gadsden’s Wharf, where tens of thousands of enslaved Africans arrived in America, the genesis of generations of health disparities.

What the Health? From KFF Health News: Live From Aspen: Three HHS Secretaries on What the Job Is Really Like

What does a day in the life of the nation’s top health official really look like? And how much of their agenda is set by the White House? In this special episode of KFF Health News’ “What the Health?” — taped before a live audience at Aspen Ideas: Health, part of the Aspen Ideas Festival, in Aspen, Colorado — host and chief Washington correspondent Julie Rovner leads a rare conversation with the current and two former U.S. secretaries of Health and Human Services. Secretary Xavier Becerra and former secretaries Kathleen Sebelius and Alex Azar talk candidly about what it takes to run a department with more than 80,000 employees and a budget larger than those of many countries.

What Does a Chatbot Know About Eating Disorders? Users of a Help Line Are About to Find Out

The National Eating Disorders Association’s help line has seen demand climb to unsustainable levels since the beginning of the covid pandemic, with more people reporting severe mental health problems, the nonprofit says. But staffers worry this chatbot may make things worse.

How the Mixed Messaging of Vaccine Skeptics Sows Seeds of Doubt

Some GOP members of the House Select Subcommittee on the Coronavirus Pandemic have two-stepped around vaccine skepticism, proclaiming themselves to be pro-vaccine while also validating the beliefs of people who oppose vaccine mandates. The result could have serious public health consequences.

What the Health? From KFF Health News: Debt Deal Leaves Health Programs (Mostly) Intact

The bipartisan deal to extend the U.S. government’s borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program’s new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Sarah Jane Tribble, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about the perils of visiting the U.S. with European health insurance.

California Confronts the Threat of ‘Tranq’ as Overdose Crisis Rages

California officials are stepping up efforts to combat the spread of xylazine, a powerful animal sedative that’s increasingly being used by people, often with devastating results. It’s mostly been an East Coast phenomenon, but ‘tranq,’ as it is known, is beginning to appear in the Golden State.

Mood-Altering Mushroom Sales Bloom Despite Safety Concerns

The well-known “Amanita muscaria” mushroom is legal to possess and consume in 49 states. The market for gummies, powders, and capsules containing extracts of the fungus is raising eyebrows, though, amid concerns from the FDA and in the absence of human clinical trials.